Kalina received her master’s degrees in Molecular Biotechnology and Biology at the Jagiellonian University in Krakow (Poland). In November 2022, she defended her PhD thesis entitled “Application of human induced pluripotent stem cells and CRISPR/Cas9 gene editing technology for investigation of molecular background of Duchenne muscular dystrophy-related cardiomyopathy”.
Currently, Kalina works as a post-doc in the group of prof. Peter van der Meer on the inter-individual susceptibility to heart failure in PLN mutation carriers.